THE IMPACT OF DIFFERENT HTA FRAMEWORKS ON TIME TO PATIENT ACCESS: A CASE STUDY ASSESSING THE FIRST COMMERCIAL LAUNCH INDICATIONS FOR LYNPARZA, TAGRISSO, IMFINZI, CALQUENCE AND ENHERTU

Crean, B; Parry, D; Horsfield, A; Ryan, J; Oraiopoulos, N

VALUE IN HEALTH, 2023; 26 (12): S379